Sarasin & Partners LLP Eli Lilly & CO Transaction History

Sarasin & Partners LLP

$10.6 Billion
Q3 2024

A detailed history of Sarasin & Partners LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Sarasin & Partners LLP holds 240,235 shares of LLY stock, worth $191 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares

240,235

Previous 314,421 23.59%

Holding current value

$191 Million

Previous $285 Million 25.24%

% of portfolio

2.01%

Previous 2.52%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$772.14 - $960.02 $57.3 Million - $71.2 Million	-74,186 Reduced 23.59%	240,235 $213 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $28 Million - $35.1 Million	38,597 Added 13.99%	314,421 $285 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $16.8 Million - $22.4 Million	28,335 Added 11.45%	275,824 $215 Million
Q4 2023 Jan 09, 2024	BUY	$525.19 - $619.13 $125 Million - $147 Million	237,478 Added 2372.17%	247,489 $144 Million
Q3 2023 Oct 05, 2023	BUY	$434.7 - $599.3 $4.35 Million - $6 Million	10,011 New	10,011 $5.38 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $30.6 Million - $35.9 Million	-98,358 Reduced 76.99%	29,396 $10.1 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $30.6 Million - $35.9 Million	98,358 Added 334.6%	127,754 $43.9 Million
Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $7.15 Million - $8.33 Million	-22,244 Reduced 43.08%	29,396 $10.8 Million
Q3 2022 Oct 18, 2022	SELL	$296.48 - $337.87 $9.58 Million - $10.9 Million	-32,319 Reduced 38.49%	51,640 $16.7 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $12.2 Million - $14.3 Million	-43,795 Reduced 34.28%	83,959 $27.2 Million
Q2 2021 Jul 13, 2021	BUY	$180.55 - $233.54 $989,594 - $1.28 Million	5,481 Added 4.48%	127,754 $29.3 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $5.04 Million - $6.53 Million	-30,696 Reduced 20.07%	122,273 $22.8 Million
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $3.01 Million - $3.98 Million	23,081 Added 17.77%	152,969 $25.8 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $10.6 Million - $12.2 Million	72,299 Added 125.54%	129,888 $19.2 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $1.55 Million - $1.92 Million	13,049 Added 29.3%	57,589 $7.99 Million
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $1.83 Million - $1.99 Million	17,136 Added 62.53%	44,540 $4.98 Million
Q2 2019 Jul 18, 2019	BUY	$110.79 - $129.32 $131,950 - $154,020	1,191 Added 4.54%	27,404 $3.04 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $750,619 - $840,920	-7,088 Reduced 21.28%	26,213 $3.03 Million
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $2.86 Million - $3.57 Million	33,301 New	33,301 $3.57 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account

Sarasin & Partners LLP Eli Lilly & CO Transaction History